Source: centralcharts

Press Release: SCYNEXIS : SCYNEXIS to Participate in the 2024 Maxim Healthcare Virtual Summit

JERSEY CITY, N.J., Oct. 10, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and

Read full article »
SCYNEXIS's Competitors | SCYNEXIS's News | SCYNEXIS's Financials
Stay up-to-date with the latest news on SCYNEXIS
Annual Revenue
$100K-5.0M
Employees
25-100
Marco Taglietti's photo - President & CEO of SCYNEXIS

President & CEO

Marco Taglietti

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on SCYNEXIS